Ki Summary BindingDB logo
myBDB logout
Reaction Details
Report a problem with these data
TargetGTPase KRas
LigandBDBM50579990
Substrate/Competitorn/a
Meas. Tech.ChEMBL_2146126 (CHEMBL5030406)
IC50 26±n/a nM
Citation Rosse, G A Series of Pyrazole Analogs Binding to KRASG12C as Potential Cancer Treatment. ACS Med Chem Lett13:11-12 (2022) [PubMed]  Article
More Info.:Get all data from this article,  Assay Method
 
GTPase KRas
Name:GTPase KRas
Synonyms:GTPase KRas, N-terminally processed | K-Ras 2 | KRAS | KRAS2 | Ki-Ras | RASK2 | RASK_HUMAN | c-K-ras | c-Ki-ras
Type:PROTEIN
Mol. Mass.:21656.10
Organism:Homo sapiens (Human)
Description:ChEMBL_1476955
Residue:189
Sequence:
MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAG
QEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDL
PSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGC
VKIKKCIIM
Blast this sequence in BindingDB or PDB
  Blast E-value cutoff:
BDBM50579990
n/a
NameBDBM50579990
Synonyms:CHEMBL5081366 | US11702409, Example 52b
TypeSmall organic molecule
Emp. Form.C29H30ClN5O3
Mol. Mass.532.033
SMILESCc1c(c(nn1C1CC2(C1)CN(C2)C(=O)C=C)-c1ccc(OCCO)cc1)-c1c(Cl)c(C)cc2[nH]ncc12 |(30.48,-32.18,;31.94,-31.7,;33.19,-32.6,;34.43,-31.69,;33.95,-30.23,;32.41,-30.23,;31.51,-28.99,;31.75,-27.46,;30.22,-27.22,;29.99,-28.75,;30.62,-25.73,;29.13,-25.34,;28.73,-26.83,;28.35,-24,;29.12,-22.67,;26.81,-24.01,;26.04,-22.67,;35.9,-32.16,;37.03,-31.13,;38.49,-31.59,;38.83,-33.1,;40.29,-33.57,;41.43,-32.53,;42.9,-33,;44.04,-31.96,;37.69,-34.14,;36.22,-33.67,;33.2,-34.14,;31.88,-34.91,;30.54,-34.14,;31.87,-36.46,;30.54,-37.22,;33.21,-37.23,;34.54,-36.45,;36.01,-36.92,;36.91,-35.68,;36.01,-34.43,;34.54,-34.9,)|
Structure
Search PDB for entries with ligand similarity:Similarity to this molecule at least: